| |
CASE STUDIES: 3
| Patient |
Profile |
Guideline Recommendation |
 |
| Age: |
28 |
| Sexually Active: |
Yes |
| Regular Medical Care: |
Non-compliant |
 |
| Pap/HPV Results |
| Historical: |
NILM, Never tested for HPV |
| Current: |
LSIL, High-risk HPV "positive" |
|
|
ASCCP and ACOG guidelines recommend conservative care for women under 30 although colposcopy should be considered. |
|
The Cervical DNA Dtex® Test Result
|
|
Actual Patient Images Cen7 3q 5p
|
Note: The Cervical DNA Dtex® test was developed and its performance characteristics determined by NeoDiagnostix, Inc. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test may be used for clinical or research purposes. The NeoDiagnostix laboratory (Rockville, MD) is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA Certificate No. 21D1047391) as qualified to perform high-complexity clinical laboratory testing. Specimens are submitted as single tests and are not associated with other diagnostic testing. Results should be interpreted with caution using other clinical information.
|
|
|
